MediciNova
MNOV
39 hedge funds and large institutions have $29M invested in MediciNova in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 18 closing their positions.
597% more call options, than puts
Call options by funds: $439K | Put options by funds: $63K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.63% less ownership
Funds ownership: 17.25% → 15.62% (-1.6%)
19% less capital invested
Capital invested by funds: $35.8M → $29M (-$6.76M)
29% less funds holding
Funds holding: 55 → 39 (-16)
31% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 16
89% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$319K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$296K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$235K |
| 4 |
Barclays
London,
United Kingdom
|
+$201K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.14M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$715K |
| 3 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$360K |
| 4 |
Jane Street
New York
|
-$352K |
| 5 |
E
Ergoteles
New York
|
-$315K |
MNOV Hedge Fund Activity: Q3 2021 in Review
39 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q3 2021, worth a combined $29M — down 19% from $35.8M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of MNOV and 2 opened new positions — a net loss of 16 holders — while 16 trimmed existing stakes and 11 added.
The largest buyer was Susquehanna International Group, adding an estimated $319K. The largest seller was Millennium Management, cutting an estimated $1.14M.
- 39 institutional investors held MediciNova (MNOV) as of Q3 2021, down from 55 in Q2 2021.
- Funds reported $29M of MediciNova stock for Q3 2021, down 19% quarter-over-quarter.
- 2 funds opened new MediciNova positions in Q3 2021 and 18 closed out, a net change of -16 holders.
- The largest MediciNova buyer in Q3 2021 was Susquehanna International Group, an estimated $319K added.
- The largest MediciNova seller in Q3 2021 was Millennium Management, an estimated $1.14M sold.
Based on aggregated 13F filings for Q3 2021.